Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 1
1973 4
1978 1
1984 1
1989 1
1990 4
1991 1
1993 1
1994 3
1995 1
1999 1
2001 4
2003 2
2004 4
2005 3
2006 2
2007 3
2008 2
2009 2
2010 2
2011 4
2012 5
2013 7
2015 3
2016 4
2017 8
2018 5
2019 10
2020 16
2021 11
2022 12
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Pugashetti JV, Adegunsoye A, Wu Z, Lee CT, Srikrishnan A, Ghodrati S, Vo V, Renzoni EA, Wells AU, Garcia CK, Chua F, Newton CA, Molyneaux PL, Oldham JM. Pugashetti JV, et al. Among authors: chua f. Am J Respir Crit Care Med. 2023 Jan 1;207(1):69-76. doi: 10.1164/rccm.202201-0124OC. Am J Respir Crit Care Med. 2023. PMID: 35943866 Free PMC article.
Lung function trajectory in progressive fibrosing interstitial lung disease.
Oldham JM, Lee CT, Wu Z, Bowman WS, Pugashetti JV, Dao N, Tonkin J, Seede H, Echt G, Adegunsoye A, Chua F, Maher TM, Garcia CK, Strek ME, Newton CA, Molyneaux PL. Oldham JM, et al. Among authors: chua f. Eur Respir J. 2022 Jun 16;59(6):2101396. doi: 10.1183/13993003.01396-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34737223 Free PMC article.
Evaluating disease severity in idiopathic pulmonary fibrosis.
Robbie H, Daccord C, Chua F, Devaraj A. Robbie H, et al. Among authors: chua f. Eur Respir Rev. 2017 Sep 6;26(145):170051. doi: 10.1183/16000617.0051-2017. Print 2017 Sep 30. Eur Respir Rev. 2017. PMID: 28877976 Free PMC article. Review.
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.
Raman L, Stewart I, Barratt SL, Chua F, Chaudhuri N, Crawshaw A, Gibbons M, Hogben C, Hoyles R, Kouranos V, Martinovic J, Mulholland S, Myall KJ, Naqvi M, Renzoni EA, Saunders P, Steward M, Suresh D, Thillai M, Wells AU, West A, Mitchell JA, George PM. Raman L, et al. Among authors: chua f. ERJ Open Res. 2023 Mar 20;9(2):00423-2022. doi: 10.1183/23120541.00423-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36949962 Free PMC article.
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases.
Barnett JL, Maher TM, Quint JK, Adamson A, Wu Z, Smith DJF, Rawal B, Nair A, Walsh SLF, Desai SR, George PM, Kokosi M, Jenkins G, Kouranos V, Renzoni EA, Rice A, Nicholson AG, Chua F, Wells AU, Molyneaux PL, Devaraj A. Barnett JL, et al. Among authors: chua f. Am J Respir Crit Care Med. 2023 Nov 1;208(9):975-982. doi: 10.1164/rccm.202305-0796OC. Am J Respir Crit Care Med. 2023. PMID: 37672028
Airway and parenchymal manifestations of pulmonary aspergillosis.
Tunnicliffe G, Schomberg L, Walsh S, Tinwell B, Harrison T, Chua F. Tunnicliffe G, et al. Among authors: chua f. Respir Med. 2013 Aug;107(8):1113-23. doi: 10.1016/j.rmed.2013.03.016. Epub 2013 May 20. Respir Med. 2013. PMID: 23702091 Free article. Review.
139 results